Mucor circinelloides as a Cause of Invasive Maxillofacial Zygomycosis: an Emerging Dimorphic Pathogen with Reduced Susceptibility to Posaconazole
Authors:
- 1 April 2009
- journal article
- case report
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 47 (4) , 1244-1248
Abstract
A case of maxillofacial zygomycosis caused by Mucor circinelloides , identified by phenotypic and molecular methods and treated successfully with liposomal amphotericin B (AmBisome) and surgical debridement, is described. The isolate was resistant to posaconazole. This report underscores the importance of prior susceptibility testing of zygomycetes to guide therapy with the most effective antifungal agent for an improved prognosis.Keywords
This publication has 41 references indexed in Scilit:
- Posaconazole as first line treatment for disseminated zygomycosisMycoses, 2008
- Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patientAntonie van Leeuwenhoek, 2008
- Posaconazole: A Broad-Spectrum Triazole Antifungal AgentClinical Infectious Diseases, 2007
- Diagnostic value of DNA, (1-3)-β-d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreusDiagnostic Microbiology and Infectious Disease, 2007
- In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2007
- Posaconazole Treatment for Apophysomyces elegans Rhino-Orbital Zygomycosis following Trauma for a Male with Well-Controlled DiabetesJournal of Clinical Microbiology, 2007
- In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the EtestAntimicrobial Agents and Chemotherapy, 2007
- Mucor circinelloides Was Identified by Molecular Methods as a Cause of Primary Cutaneous ZygomycosisJournal of Clinical Microbiology, 2007
- Zygomycosis: the re-emerging fungal infectionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell TransplantsNew England Journal of Medicine, 2004